27
May
Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was supported by export momentum and expansion in the Medical Devices business, while operational momentum strengthened toward the latter part of FY26. Morepen Labs Q4 FY2026 Financial Results Quarterly and Annual Highlights Gross revenue grew 22% YoY to Rs. 472 Cr in Q4 FY26 Net profit increased 69% YoY to Rs. 20 Cr in Q4 FY26 API business grew 17% in Q4 FY26 Medical Devices…
